INITIAL TREATMENT DOSE AND REASONS FOR DOSE ADJUSTMENT DURING ORAL CAPECITABINE CHEMOTHERAPY

被引：0
|
作者：
von Moos, R. [1 ]
Delmore, G. [2 ]
Hoesli, P. [3 ]
Huegli-Dayer, A.
Mannhart, M. [4 ]
Otto, F. [5 ]
Pederiva, S. [6 ]
van Lier, M. [7 ]
Nick, S. [7 ]
Winterhalder, R. [8 ]
机构：
[1] Kantonsspital Graubunden, Dept Oncol, Chur, Switzerland
[2] Kantonsspital Frauenfeld, Frauenfeld, Switzerland
[3] Hop Yverdon Les Bains, Yverdon, Switzerland
[4] Hislanden Andreasklin, Cham, Switzerland
[5] ZetuP, St Gallen, Switzerland
[6] Med Zentrum Brugg AG, Oncol, Brugg, Switzerland
[7] Roche Pharma Schweiz AG, Reinach, Switzerland
[8] Kantonsspital Luzern, Luzern, Switzerland
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：247 / 247
页数：1
相关论文
共 50 条
  • [1] Learning the dose adjustment for the oral anticoagulation treatment
    Gamberoni, G
    Lamma, E
    Mello, P
    Pavesi, P
    Storari, S
    Trocino, G
    [J]. BIOLOGICAL AND MEDICAL DATA ANALYSIS, PROCEEDINGS, 2004, 3337 : 171 - 181
  • [2] Clinical impact of standardized creatinine on dose adjustment of capecitabine
    Ito, Ayaka
    Ichikawa, Kazuya
    Miyazaki, Masayuki
    Sagara, Atsunobu
    Motegi, Toshiki
    Ando, Yuichi
    Senzaki, Koji
    Nagai, Taku
    Yamada, Kiyofumi
    [J]. NAGOYA JOURNAL OF MEDICAL SCIENCE, 2022, 84 (03): : 547 - 553
  • [3] PROVIDER ADHERENCE TO ORAL CHEMOTHERAPY DOSE ADJUSTMENT GUIDELINES IN THE TREATMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Fowler, Amy
    Leonard, David
    Slone, Tamra
    Tellinghuisen, Christian
    Kennedy, Alexis
    Griffith, Patrice
    Winick, Naomi
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [4] Individual dose adjustment in cancer chemotherapy
    Gamelin, E
    BoisdronCelle, M
    [J]. REVUE DE MEDECINE INTERNE, 1996, 17 (07): : 529 - 534
  • [5] Dose adjustment and supportive care before and during treatment
    Brunello, Antonella
    Loaldi, Elena
    Balducci, Lodovico
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (06) : 493 - 498
  • [6] Oral Low-Dose Chemotherapy: Successful Treatment of an Alveolar Rhabdomyosarcoma During Pregnancy
    Siepermann, Meinolf
    Koscielniak, Ewa
    Dantonello, Tobias
    Klee, Dirk
    Boos, Joachim
    Krefeld, Barbara
    Borkhardt, Arndt
    Hoehn, Thomas
    Asea, Alexzander
    Wessalowski, Ruediger
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 58 (01) : 104 - 106
  • [7] The MADO study of the need, reasons and strategies for dose adjustment in allergen immunotherapy: treatment benefits
    Thetis-Soulie, M.
    Baillez, C.
    Mercier, V
    Hosotte, M.
    Scurati, S.
    Grozelier, I
    [J]. ALLERGY, 2021, 76 : 42 - 43
  • [8] Tailored-dose capecitabine chemotherapy as adjuvant treatment in elderly colon cancer patients
    Chang, Hye Jung
    Lee, Keun-Wook
    Choi, In Sil
    Kim, Yu Jung
    Kim, Jee Hyun
    Bang, Soo-Mee
    Lee, Jong-Seok
    [J]. CANCER RESEARCH, 2010, 70
  • [9] A Chemotherapy-Diffusion Model for the Cancer Treatment and Initial Dose Control
    Abdel-Gawad, Hamdy Ibrahim
    Saad, Khaled Mohammed
    [J]. KYUNGPOOK MATHEMATICAL JOURNAL, 2008, 48 (03): : 395 - 410
  • [10] Oral idarubicin and oral capecitabine in the treatment of locally advanced or advanced breast cancer - A dose finding study
    Nussey, F
    Afseth, J
    Murray, E
    Bowman, A
    Leonard, R
    Cameron, D
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 : S22 - S22
12345